Injective CEO rings Nasdaq bell as Canary’s staked INJ ETF begins trading

Canary's INJC staked Injective ETF debuted on Nasdaq on Nov. 5 and held $16.12 million in assets by Friday, with 600,000 shares and staking built in.
This story was originally published by crypto.news.





